<\/a>Charles West<\/p><\/div>\n
Charles West, colorectal surgery research fellow at the University of Southampton and study lead, said: \u201cPatients presenting with cancers in the abdomen and pelvis that are very advanced at diagnosis or have come back after previous treatment are difficult to manage. Survival is poor unless surgery is performed to remove all the cancer, however, while these procedures are life-saving, they can be very invasive and leave large wounds that can cause complications and reduced quality of life for patients. The full impact on quality of life is not well known about currently. There are methods of reconstruction available to improve quality of life, however, doctors are not currently sure which method of reconstruction gives the best outcomes, which is something the REMACS study hopes to establish.\u201d<\/p>\n
He added: \u201cThe participation and support of patients like Sharon is invaluable and, through sharing her story, she is helping us to increase interest and involvement in the study which will undoubtedly lead to improvements in quality of life for patients in the future.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
Sharon Applin, was diagnosed with a skin cancer in 2020 which was initially treated successfully with chemotherapy and radiotherapy. However, by the start of 2022 she began feeling unwell with bleeding, diarrhoea and severe pain. Tests confirmed she was suffering from cancer affecting the abdomen and pelvis which would require major surgery. Sharon was told […]<\/p>\n","protected":false},"author":42,"featured_media":42536,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[11],"tags":[],"yoast_head":"\n
Sharon Applin - Pelvic Exenteration - PLANETS Charity<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n\n\t\n\t\n\t\n